Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.

• Main Authors: Evelyn M Covés-Datson (Author), Julie Dyall (Author), Lisa Evans DeWald (Author), Steven R King (Author), Derek Dube (Author), Maureen Legendre (Author), Elizabeth Nelson (Author), Kelly C Drews (Author), Robin Gross (Author), Dawn M Gerhardt (Author), Lisa Torzewski (Author), Elena Postnikova (Author), Janie Y Liang (Author), Bhupal Ban (Author), Jagathpala Shetty (Author), Lisa E Hensley (Author), Peter B Jahrling (Author), Gene G Olinger (Author), Judith M White (Author), David M Markovitz (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, especially in the face of an ongoing outbreak in the...